Reported number of people receiving antiretroviral therapy in Sierra Leone
Sierra Leone: Reported number of people receiving antiretroviral therapy was 77,513 in 2025. ◆ Volatile
Reported number of people receiving antiretroviral therapy in Sierra Leone, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, reported number of people receiving antiretroviral therapy in Sierra Leone stood at 77,513. That is the highest value across all 26 years on record.
Compared with earlier readings it is up 11.4% on the previous year and up 446.0% over ten years.
Over the whole period, reported number of people receiving antiretroviral therapy in Sierra Leone peaked at 77,513 in 2025 and was at its lowest, 0, in 2000.
Sierra Leone ranks 42nd of 143 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Reported number of people receiving antiretroviral therapy in Sierra Leone, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0 | — |
| 2001 | 0 | — |
| 2002 | 0 | — |
| 2003 | 0 | — |
| 2004 | 0 | — |
| 2005 | 317 | — |
| 2006 | 753 | +137.5% |
| 2007 | 1,062 | +41.0% |
| 2008 | 2,087 | +96.5% |
| 2009 | 3,916 | +87.6% |
| 2010 | 5,978 | +52.7% |
| 2011 | 7,259 | +21.4% |
| 2012 | 8,261 | +13.8% |
| 2013 | 9,173 | +11.0% |
| 2014 | 10,775 | +17.5% |
| 2015 | 14,196 | +31.7% |
| 2016 | 18,476 | +30.1% |
| 2017 | 23,646 | +28.0% |
| 2018 | 28,402 | +20.1% |
| 2019 | 33,363 | +17.5% |
| 2020 | 37,954 | +13.8% |
| 2021 | 47,715 | +25.7% |
| 2022 | 56,306 | +18.0% |
| 2023 | 61,274 | +8.8% |
| 2024 | 69,572 | +13.5% |
| 2025 | 77,513 | +11.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 813.5 | 0 | 3,916 | 10 |
| 2010s | 15,953 | 5,978 | 33,363 | 10 |
| 2020s | 58,389 | 37,954 | 77,513 | 6 |
Countries ranked near Sierra Leone
More health data for Sierra Leone
- Un projection of annual infant deaths, annual growth rate -2.34 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.773 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,199 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4,209 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 38 (2025)
- Population ages 00-04, female, annual growth rate 0.6447 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0663 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.6611 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is reported number of people receiving antiretroviral therapy in Sierra Leone?
- Reported number of people receiving antiretroviral therapy in Sierra Leone was 77,513 in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest reported number of people receiving antiretroviral therapy recorded in Sierra Leone?
- The highest recorded value was 77,513 in 2025.
- What is the lowest reported number of people receiving antiretroviral therapy recorded in Sierra Leone?
- The lowest recorded value was 0 in 2000.
- How does Sierra Leone rank for reported number of people receiving antiretroviral therapy?
- Sierra Leone ranks 42nd out of 143 countries with data for 2025.
- Is reported number of people receiving antiretroviral therapy rising or falling in Sierra Leone?
- Over the last ten years it is up 446.0%. The long-run trend across the full record is volatile.
- Where does this Sierra Leone data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Reported number of people receiving antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).